NCT04634721View on ClinicalTrials.gov

Transversus Abdominis Plan Block, Ultrasound or Laparoscopic?

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

January 15, 2021

Conditions
BupivacaineAnesthetics, LocalAnestheticsPeripheral Nervous System Agents
Interventions
DRUG

bupivacaine

In one arm the TAP infiltration will contain 10 mL of 0.25 % bupivacaine injected . This will then be repeated on the contralateral side.

Trial Locations (1)

Unknown

Ankara Şehir Hastanesi, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT04634721 - Transversus Abdominis Plan Block, Ultrasound or Laparoscopic? | Biotech Hunter | Biotech Hunter